Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 338

1.

Bilateral Xp11.2 translocation renal cell carcinoma: a case report.

Karashima T, Kuno T, Kuroda N, Satake H, Fukata S, Chikazawa M, Kawada C, Yamasaki I, Shuin T, Hiroi M, Inoue K.

BMC Urol. 2018 Nov 20;18(1):106. doi: 10.1186/s12894-018-0419-3.

2.

Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.

Nakai Y, Inoue K, Tsuzuki T, Shimamoto T, Shuin T, Nagao K, Matsuyama H, Oyama M, Furuse H, Ozono S, Miyake M, Fujimoto K.

Int J Urol. 2018 Aug;25(8):723-729. doi: 10.1111/iju.13718. Epub 2018 Jul 12.

3.

SHISA2 enhances the aggressive phenotype in prostate cancer through the regulation of WNT5A expression.

Tamura K, Furihata M, Satake H, Hashida H, Kawada C, Osakabe H, Fukuhara H, Kumagai N, Iiyama T, Shuin T, Inoue K.

Oncol Lett. 2017 Dec;14(6):6650-6658. doi: 10.3892/ol.2017.7099. Epub 2017 Sep 28.

4.

Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.

Nakagawa M, Karashima T, Kamada M, Yoshida E, Yoshimura T, Nojima M, Inoue K, Shuin T, Seiki M, Koshikawa N.

Biomark Res. 2017 Oct 13;5:29. doi: 10.1186/s40364-017-0109-4. eCollection 2017.

5.

Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model.

Karashima T, Udaka K, Niimura M, Suzuki K, Osakabe H, Shimamoto T, Fukata S, Inoue K, Kuroda N, Seiki M, Shuin T.

Oncol Lett. 2017 Jul;14(1):1162-1166. doi: 10.3892/ol.2017.6235. Epub 2017 May 24.

6.

5-aminolevulinic acid combined with ferrous ion reduces adiposity and improves glucose tolerance in diet-induced obese mice via enhancing mitochondrial function.

Ota U, Hara T, Nakagawa H, Tsuru E, Tsuda M, Kamiya A, Kuroda Y, Kitajima Y, Koda A, Ishizuka M, Fukuhara H, Inoue K, Shuin T, Nakajima M, Tanaka T.

BMC Pharmacol Toxicol. 2017 Jan 30;18(1):7. doi: 10.1186/s40360-016-0108-3.

7.

Development of Database and Genomic Medicine for von Hippel-Lindau Disease in Japan.

Takayanagi S, Mukasa A, Nakatomi H, Kanno H, Kuratsu JI, Nishikawa R, Mishima K, Natsume A, Wakabayashi T, Houkin K, Terasaka S, Yao M, Shinohara N, Shuin T, Saito N.

Neurol Med Chir (Tokyo). 2017 Feb 15;57(2):59-65. doi: 10.2176/nmc.ra.2016-0206. Epub 2017 Jan 6. Review.

8.

A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder.

Obara W, Eto M, Mimata H, Kohri K, Mitsuhata N, Miura I, Shuin T, Miki T, Koie T, Fujimoto H, Minami K, Enomoto Y, Nasu T, Yoshida T, Fuse H, Hara I, Kawaguchi K, Arimura A, Fujioka T.

Ann Oncol. 2017 Apr 1;28(4):798-803. doi: 10.1093/annonc/mdw675.

PMID:
27998971
9.

[Undifferentiated Prostate Cancer Treated with Radiation Therapy].

Osakabe H, Tamura K, Yamasaki I, Fukata S, Ashida S, Hiroi M, Tanimura M, Inoue K, Shuin T.

Hinyokika Kiyo. 2016 Nov;62(11):599-604. doi: 10.14989/ActaUrolJap_62_11_599. Japanese.

10.

Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.

Nakayama T, Otsuka S, Kobayashi T, Okajima H, Matsumoto K, Hagiya Y, Inoue K, Shuin T, Nakajima M, Tanaka T, Ogura SI.

Sci Rep. 2016 Nov 18;6:36478. doi: 10.1038/srep36478.

11.

Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.

Middlebrooks CD, Banday AR, Matsuda K, Udquim KI, Onabajo OO, Paquin A, Figueroa JD, Zhu B, Koutros S, Kubo M, Shuin T, Freedman ND, Kogevinas M, Malats N, Chanock SJ, Garcia-Closas M, Silverman DT, Rothman N, Prokunina-Olsson L.

Nat Genet. 2016 Nov;48(11):1330-1338. doi: 10.1038/ng.3670. Epub 2016 Sep 19.

12.

Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma.

Obara W, Karashima T, Takeda K, Kato R, Kato Y, Kanehira M, Takata R, Inoue K, Katagiri T, Shuin T, Nakamura Y, Fujioka T.

Cancer Immunol Immunother. 2017 Jan;66(1):17-24. doi: 10.1007/s00262-016-1915-5. Epub 2016 Oct 18.

13.

[Molecules associated with invasion and metastasis in prostate cancer].

Ashida S, Inoue K, Shuin T.

Nihon Rinsho. 2016 May 20;74 Suppl 3:135-9. Japanese. No abstract available.

PMID:
27344717
14.

Feasibility and early outcome of high-dose-rate Ir-192 brachytherapy as monotherapy in two fractions within 1 day for high-/very high-risk prostate cancer.

Ashida S, Yamasaki I, Tamura K, Shimamoto T, Inoue K, Kariya S, Kobayashi K, Yamagami T, Shuin T.

Mol Clin Oncol. 2016 May;4(5):789-793. Epub 2016 Feb 22.

15.

Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.

Okumura F, Uematsu K, Byrne SD, Hirano M, Joo-Okumura A, Nishikimi A, Shuin T, Fukui Y, Nakatsukasa K, Kamura T.

Mol Cell Biol. 2016 May 31;36(12):1803-17. doi: 10.1128/MCB.00067-16. Print 2016 Jun 15.

16.

Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease.

Kobayashi A, Takahashi M, Imai H, Akiyama S, Sugiyama S, Komine K, Saijo K, Takahashi M, Takahashi S, Shirota H, Sato N, Fujishima F, Shuin T, Shimodaira H, Ishioka C.

Intern Med. 2016;55(6):629-34. doi: 10.2169/internalmedicine.55.5796. Epub 2016 Mar 15.

17.

Phytoestrogen Suppresses Efflux of the Diagnostic Marker Protoporphyrin IX in Lung Carcinoma.

Fujita H, Nagakawa K, Kobuchi H, Ogino T, Kondo Y, Inoue K, Shuin T, Utsumi T, Utsumi K, Sasaki J, Ohuchi H.

Cancer Res. 2016 Apr 1;76(7):1837-46. doi: 10.1158/0008-5472.CAN-15-1484. Epub 2016 Feb 2.

18.

The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).

Inoue K, Matsuyama H, Fujimoto K, Hirao Y, Watanabe H, Ozono S, Oyama M, Ueno M, Sugimura Y, Shiina H, Mimata H, Azuma H, Nagase Y, Matsubara A, Ito YM, Shuin T.

Photodiagnosis Photodyn Ther. 2016 Mar;13:91-96. doi: 10.1016/j.pdpdt.2015.12.011. Epub 2016 Jan 2.

PMID:
26751700
19.

Chromophobe renal cell carcinoma, eosinophilic variant with papillary growth: a case report.

Karashima T, Kuroda N, Taguchi T, Matsumoto M, Hiroi M, Nao T, Fukata S, Inoue K, Shuin T.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13590-5. eCollection 2015.

20.

Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.

Kamada M, Koshikawa N, Minegishi T, Kawada C, Karashima T, Shuin T, Seiki M.

Cancer Sci. 2015 Dec;106(12):1730-7. doi: 10.1111/cas.12832. Epub 2015 Nov 6.

21.

Silencing of ATPase Inhibitory Factor 1 Inhibits Cell Growth via Cell Cycle Arrest in Bladder Cancer.

Wei S, Fukuhara H, Kawada C, Kurabayashi A, Furihata M, Ogura S, Inoue K, Shuin T.

Pathobiology. 2015;82(5):224-32. doi: 10.1159/000439027. Epub 2015 Sep 19.

22.

The Utility of a Flexible Fluorescence-Cystoscope with a Twin Mode Monitor for the 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis of Bladder Cancer.

Fukuhara H, Kureishi M, Khoda T, Inoue K, Tanaka T, Iketani K, Orita M, Inoue K, Shuin T.

PLoS One. 2015 Sep 2;10(9):e0136416. doi: 10.1371/journal.pone.0136416. eCollection 2015.

23.

Clinical applications of 5-aminolevulinic acid-mediated fluorescence for gastric cancer.

Namikawa T, Yatabe T, Inoue K, Shuin T, Hanazaki K.

World J Gastroenterol. 2015 Aug 7;21(29):8769-75. doi: 10.3748/wjg.v21.i29.8769. Review.

24.

Performance of 5-aminolevulinic-acid-based photodynamic diagnosis for radical prostatectomy.

Fukuhara H, Inoue K, Kurabayashi A, Furihata M, Shuin T.

BMC Urol. 2015 Aug 1;15:78. doi: 10.1186/s12894-015-0073-y.

25.

Plasma protoporphyrin IX following administration of 5-aminolevulinic acid as a potential tumor marker.

Ota U, Fukuhara H, Ishizuka M, Abe F, Kawada C, Tamura K, Tanaka T, Inoue K, Ogura SI, Shuin T.

Mol Clin Oncol. 2015 Jul;3(4):797-801. Epub 2015 Apr 24.

26.

Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

Kurabayashi A, Inoue K, Fukuhara H, Karashima T, Fukata S, Kawada C, Shuin T, Furihata M.

Cancer Sci. 2015 Aug;106(8):1092-9. doi: 10.1111/cas.12711. Epub 2015 Jul 14.

27.

Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.

Inoue K, Anai S, Fujimoto K, Hirao Y, Furuse H, Kai F, Ozono S, Hara T, Matsuyama H, Oyama M, Ueno M, Fukuhara H, Narukawa M, Shuin T.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):193-200. doi: 10.1016/j.pdpdt.2015.03.008. Epub 2015 Apr 2.

PMID:
25843912
28.

The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid.

Hayashi M, Fukuhara H, Inoue K, Shuin T, Hagiya Y, Nakajima M, Tanaka T, Ogura S.

PLoS One. 2015 Mar 30;10(3):e0122351. doi: 10.1371/journal.pone.0122351. eCollection 2015.

29.

IgG4-related disease of the paratestis in a patient with Wells syndrome: a case report.

Karashima T, Taniguchi Y, Shimamoto T, Nao T, Nishikawa H, Fukata S, Kamada M, Inoue K, Oko K, Nakajima H, Sano S, Matsumoto M, Kuroda N, Kamei Y, Shuin T.

Diagn Pathol. 2014 Dec 9;9:225. doi: 10.1186/s13000-014-0225-5. Review.

30.

[Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].

Nao T, Shimamoto T, Karashima T, Kamei M, Fukuhara H, Fukata S, Satake H, Ashida S, Yamasaki I, Kamata M, Inoue K, Yamanishi T, Ogawa Y, Ito S, Shuin T.

Hinyokika Kiyo. 2014 Sep;60(9):415-20. Japanese.

31.

Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.

Matsuda K, Takahashi A, Middlebrooks CD, Obara W, Nasu Y, Inoue K, Tamura K, Yamasaki I, Naya Y, Tanikawa C, Cui R, Figueroa JD, Silverman DT, Rothman N, Namiki M, Tomita Y, Nishiyama H, Kohri K, Deguchi T, Nakagawa M, Yokoyama M, Miki T, Kumon H, Fujioka T, Prokunina-Olsson L, Kubo M, Nakamura Y, Shuin T.

Hum Mol Genet. 2015 Feb 15;24(4):1177-84. doi: 10.1093/hmg/ddu512. Epub 2014 Oct 3.

32.

IgG4-related tubulointerstitial nephritis accompanied with cystic formation.

Fukuhara H, Taniguchi Y, Matsumoto M, Kuroda N, Fukata S, Inoue K, Fujimoto S, Terada Y, Shuin T.

BMC Urol. 2014 Jul 20;14:54. doi: 10.1186/1471-2490-14-54.

33.

Clinical characteristics of Japanese patients with reactive arthritis following intravesical BCG therapy for bladder cancer.

Taniguchi Y, Karashima T, Yoshinaga Y, Shuin T, Fujimoto S, Terada Y.

Mod Rheumatol. 2015 Jan;25(1):161-3. doi: 10.3109/14397595.2014.926853. Epub 2014 Jun 20. No abstract available.

PMID:
24947826
34.

Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas.

Kuwada M, Chihara Y, Lou Y, Torimoto K, Kagebayashi Y, Tamura K, Shuin T, Fujimoto K, Kuniyasu H, Samma S.

BMC Res Notes. 2014 Mar 31;7:203. doi: 10.1186/1756-0500-7-203.

35.

Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo.

Wei S, Fukuhara H, Chen G, Kawada C, Kurabayashi A, Furihata M, Inoue K, Shuin T.

Pathobiology. 2014;81(3):123-32. doi: 10.1159/000357622. Epub 2014 Mar 8.

36.

Downregulation of the tumor suppressor HSPB7, involved in the p53 pathway, in renal cell carcinoma by hypermethylation.

Lin J, Deng Z, Tanikawa C, Shuin T, Miki T, Matsuda K, Nakamura Y.

Int J Oncol. 2014 May;44(5):1490-8. doi: 10.3892/ijo.2014.2314. Epub 2014 Feb 27.

37.

Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma.

Karashima T, Komatsu T, Niimura M, Kawada C, Kamada M, Inoue K, Udaka K, Kuroda N, Shuin T.

Int J Urol. 2014 Jul;21(7):702-6. doi: 10.1111/iju.12401. Epub 2014 Feb 27.

38.

Application of 5-aminolevulinic acid-mediated photodynamic diagnosis to robot-assisted laparoscopic radical prostatectomy.

Inoue K, Ashida S, Fukuhara H, Iiyama T, Miyamura M, Kurabayashi A, Furihata M, Shuin T.

Urology. 2013 Nov;82(5):1175-8.

PMID:
24358486
39.

5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.

Terada Y, Inoue K, Matsumoto T, Ishihara M, Hamada K, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Horino T, Karashima T, Tamura K, Fukuhara H, Fujimoto S, Tsuda M, Shuin T.

PLoS One. 2013 Dec 6;8(12):e80850. doi: 10.1371/journal.pone.0080850. eCollection 2013.

40.

Pathological risk factors in upper urinary tract cancer.

Shimamoto T, Inoue K, Kamata M, Kuno T, Karashima T, Shuin T.

Asia Pac J Clin Oncol. 2016 Mar;12(1):e179-88. doi: 10.1111/ajco.12155. Epub 2013 Dec 2.

PMID:
24289213
41.

Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: the potential of photodynamic screening for tumors.

Inoue K, Ota U, Ishizuka M, Kawada C, Fukuhara H, Shuin T, Okura I, Tanaka T, Ogura S.

Photodiagnosis Photodyn Ther. 2013 Dec;10(4):484-9. doi: 10.1016/j.pdpdt.2013.05.002. Epub 2013 Jun 10.

PMID:
24284101
42.

The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.

Fukuhara H, Inoue K, Kurabayashi A, Furihata M, Fujita H, Utsumi K, Sasaki J, Shuin T.

Photodiagnosis Photodyn Ther. 2013 Dec;10(4):399-409. doi: 10.1016/j.pdpdt.2013.03.003. Epub 2013 Apr 12.

PMID:
24284092
43.

Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer.

Namikawa T, Inoue K, Uemura S, Shiga M, Maeda H, Kitagawa H, Fukuhara H, Kobayashi M, Shuin T, Hanazaki K.

J Surg Oncol. 2014 Mar;109(3):213-7. doi: 10.1002/jso.23487. Epub 2013 Nov 8.

PMID:
24214406
44.

[First experiences of laparoscopic radical cystectomy].

Karashima T, Inoue K, Fukata S, Ashida S, Shimamoto T, Fukuhara H, Anchi T, Kamei M, Tamura K, Yamasaki I, Kamada M, Satake H, Shuin T.

Nihon Hinyokika Gakkai Zasshi. 2013 Sep;104(5):644-50. Japanese.

PMID:
24187851
45.

Effective treatment of metastatic renal cell carcinoma with topical imiquimod therapy.

Okino T, Fujioka A, Nakajima H, Tarutani M, Shuin T, Sano S.

J Dtsch Dermatol Ges. 2014 Feb;12(2):155-7. doi: 10.1111/ddg.12221. Epub 2013 Oct 15. No abstract available.

PMID:
24128072
46.

Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.

Hagiya Y, Fukuhara H, Matsumoto K, Endo Y, Nakajima M, Tanaka T, Okura I, Kurabayashi A, Furihata M, Inoue K, Shuin T, Ogura S.

Photodiagnosis Photodyn Ther. 2013 Sep;10(3):288-95. doi: 10.1016/j.pdpdt.2013.02.001. Epub 2013 Mar 15.

PMID:
23993855
47.

Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide.

Ueda K, Tatsuguchi A, Saichi N, Toyama A, Tamura K, Furihata M, Takata R, Akamatsu S, Igarashi M, Nakayama M, Sato TA, Ogawa O, Fujioka T, Shuin T, Nakamura Y, Nakagawa H.

J Proteome Res. 2013 Oct 4;12(10):4497-506. doi: 10.1021/pr400547s. Epub 2013 Sep 11.

PMID:
23991666
48.

Nocturia Potentially Influences Maintenance of Sexual Function in Elderly Men with Benign Prostatic Hyperplasia.

Ishizuka O, Matsuyama H, Sakai H, Matsubara A, Nagaoka A, Takahashi S, Takeda M, Ozono S, Shiroki R, Shuin T, Hara I, Kakizaki H, Tsukamoto T, Yamanishi T, Yokoyama O, Kakehi Y, Nishizawa O; KING Study Group.

Low Urin Tract Symptoms. 2013 May;5(2):75-81. doi: 10.1111/j.1757-5672.2012.00173.x. Epub 2012 Sep 21.

PMID:
26663374
49.

Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey.

Igarashi H, Ito T, Nishimori I, Tamura K, Yamasaki I, Tanaka M, Shuin T.

J Gastroenterol. 2014 Mar;49(3):511-6. doi: 10.1007/s00535-013-0794-1. Epub 2013 Mar 31.

PMID:
23543325
50.

Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.

Inoue K, Fukuhara H, Kurabayashi A, Furihata M, Tsuda M, Nagakawa K, Fujita H, Utsumi K, Shuin T.

Cancer Sci. 2013 Jun;104(6):765-72. doi: 10.1111/cas.12147. Epub 2013 Apr 17.

Supplemental Content

Support Center